Skip to main content

NEW YORK (

TheStreet

) -- Several small-cap stocks were poised to move on above-average volume during Friday's session

CryptoLogic

(CRYP)

plummeted by $1.14, or 17.8%, to $5.28 in the premarket session after the company said uncertain macroeconomic conditions and sluggish wagering activity continued in the third quarter, contributing to a significant decline in wagering volumes at CryptoLogic in both casino and poker compared with the previous year. CryptoLogic said it expects to report third-quarter revenue of approximately $9.6 million and a trading loss of approximately $3.4 million. The lone analyst polled by Thomson Reuters expects revenue of $14.3 million in the quarter. The three-month average daily volume for CryptoLogic is 80,000, according to Yahoo! Finance.

Audiocodes

(AUDC) - Get AudioCodes Ltd. Report

jumped by 25 cents, or 9.7%, to $2.82 in the premarket session after Bank of America/Merrill Lynch upgraded the stock to buy from underperform. The three-month average daily volume for Audiocodes is 70,000, according to Yahoo! Finance.

AltiGen Communications

(ATGN)

jumped by 8 cents, or 8.7%, to $1 in the premarket session after the company said it has signed an exclusive agreement with Italian distributor and telecom equipment provider

TheStreet Recommends

Hypercom

. The company will direct the sale and distribution of AltiGen's

Microsoft

(MSFT) - Get Microsoft Corporation Report

-certified applications through Telecom Italia. The three-month average daily volume for AltiGen is 24,000, according to Yahoo! Finance.

Cytori Therapeutics

(CYTX)

rose by 10 cents, or 2.7%, to $3.84 in the premarket session after the company on late Thursday said results of a procedure where stem and regenerative cells from a patient's own fat tissue were used to treat stress urinary incontinence showed the investigational treatment is "safe and feasible." The three-month average daily volume for Cytori is 289,000, according to Yahoo! Finance.

Spectrum Pharmaceuticals

(SPPI) - Get Spectrum Pharmaceuticals, Inc. Report

jumped by 35 cents, or 8%, to $4.75 in the premarket session in the absence of any company-specific news. Investor posts on Internet message boards speculated that the rise in share price was due to options expiration Friday. Others argued the company is ripe for a takeover by a larger company that could support the drugmaker's pipeline. The three-month average daily volume for Spectrum is 2.7 million, according to Yahoo! Finance.

-- Written by Robert Holmes in New York

.